Efficacy of fecal microbiota transplantation in patients with Parkinson’s disease: clinical trial results from a randomized, placebo-controlled design

Efficacy of fecal microbiota transplantation in patients with Parkinson’s disease: clinical trial results from a randomized, placebo-controlled design

ABSTRACTThe occurrence and development of Parkinson’s disease (PD) have been demonstrated to be related to gut dysbiosis, however, the impact of fecal microbiota transplantation (FMT) on microbiota engraftment in PD patients is uncertain. We performed a randomized, placebo-controlled trial at the De...

Full description

Bibliographic Details
Main Authors: Yi Cheng, Guohua Tan, Qihui Zhu, Chun Wang, Guangcong Ruan, Senhong Ying, Jinlong Qie, Xiaofei Hu, Zhifeng Xiao, Fenghua Xu, Lu Chen, Minjia Chen, Yang Pei, Hao Zhang, Yuting Tian, Dongfeng Chen, Xingyin Liu, Heqing Huang, Yanling Wei
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Gut Microbes
Subjects:
Parkinson’s disease
clinical trial
fecal microbiota transplantation
gut microbiota
microbiota-gut-brain axis
Online Access:https://www.tandfonline.com/doi/10.1080/19490976.2023.2284247

Internet

https://www.tandfonline.com/doi/10.1080/19490976.2023.2284247

Similar Items